Uracil

Uracil

SCHEMBL228901

O=c1cc[nH]c(=O)[nH]1.[Ag]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uracil SCHEMBL5089507 0.97
Uracil SCHEMBL8235 0.97
Uracil SCHEMBL3798527 0.97 CRBN (1.00)
Uracil SCHEMBL2557975 0.94
Uracil SCHEMBL2161716 0.94
Uracil SCHEMBL8767625 0.94
Uracil SCHEMBL710130 0.94
Uracil SCHEMBL18010636 0.94
Uracil SCHEMBL16116311 0.94
Uracil SCHEMBL21385227 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080156821-A1 TOPICAL PREPARATION DISPENSERS AND METHODS OF USING THE SAME GALER IP HOLDINGS, LLC 2008-07-03 US claimed
US-20070248656-A1 TOPICAL PREPARATION DISPENSERS AND METHODS OF USING THE SAME GALER IP HOLDINGS, LLC 2007-10-25 US claimed
US-4474748-A ANTIBIOTICS, FUNGICIDES, ANTISEPTICS JOHNSON & JOHNSON (US) 1984-10-02 US claimed
US-4321257-A Potentiated medicaments JOHNSON & JOHNSON (US) 1982-03-23 US claimed
US-4197318-A CYCLOHEXYL SUBSTITUTED ALKANOLS AS POTENTIATORS JOHNSON & JOHNSON (US) 1980-04-08 US claimed
US-20250143721-A1 METHODS OF TREATING DEGENERATIVE BONE CONDITIONS AGNOVOS HEALTHCARE, LLC (US) 2025-05-08 US disclosed
EP-2588154-B2 COMPOSITION COMPRISING CALCIUM PHOSPHATE, SULFATE POWDERS OR DMB USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS AGNOVOS HEALTHCARE LLC (US) 2025-04-02 EP disclosed
US-20250049986-A1 KITS FOR PREPARING A REACTIVE GRAFT MATERIAL AND INJECTING THE GRAFT MATERIAL INTO A PATIENT AGNOVOS HEALTHCARE, LLC (US) 2025-02-13 US disclosed
EP-4467169-A2 IMPROVED BONE GRAFT SUBSTITUTE FORMULATION Wright Medical Technology, Inc. (US) 2024-11-27 EP disclosed
EP-4096730-B1 IMPROVED BONE GRAFT SUBSTITUTE FORMULATION WRIGHT MEDICAL TECH INC (US) 2024-08-07 EP disclosed
US-20230347019-A1 IMPROVED BONE GRAFT SUBSTITUTE FORMULATION WRIGHT MEDICAL TECHNOLOGY, INC. 2023-11-02 US disclosed
EP-4186534-A1 METHODS OF TREATING DEGENERATIVE BONE CONDITIONS Agnovos Healthcare, LLC (US) 2023-05-31 EP disclosed
EP-0250558-B1 NOVEL COMPOUNDS AND NOVEL RECORDING MATERIAL USING THE SAME POLAROID CORPORATION (US) 1990-05-02 EP disclosed
EP-0250558-A1 NOVEL COMPOUNDS AND NOVEL RECORDING MATERIAL USING THE SAME. POLAROID CORP (US) 1988-01-07 EP disclosed
US-4474748-A ANTIBIOTICS, FUNGICIDES, ANTISEPTICS JOHNSON & JOHNSON (US) 1984-10-02 US disclosed
US-4321257-A Potentiated medicaments JOHNSON & JOHNSON (US) 1982-03-23 US disclosed
US-4200939-A USING THERMOPLASTIC RESIN CODMAN & SHURTLEFF, INC. (US) 1980-05-06 US disclosed
US-4197318-A CYCLOHEXYL SUBSTITUTED ALKANOLS AS POTENTIATORS JOHNSON & JOHNSON (US) 1980-04-08 US disclosed
US-4091090-A PENETRANT ACCELERATOR COMPRISING CYCLOHEXYL-SUBSTITUTED ALKANOLS JOHNSON & JOHNSON (US) 1978-05-23 US disclosed
US-4006218-A MICROBIOCIDE JOHNSON & JOHNSON (US) 1977-02-01 US disclosed